13
Jan
Jan
The Iranian-made medicine for amyotrophic lateral sclerosis (ALS), called Alsava, will reduce treatment costs from currently $47,000 to $5,000 per patient annually, IRNA reported.
Tag Archives: ALS medicine
The Iranian-made medicine for amyotrophic lateral sclerosis (ALS), called Alsava, will reduce treatment costs from currently $47,000 to $5,000 per patient annually, IRNA reported.